A Dose of Perspective: A Multinational Survey of Patient and Clinician Views on Combination Therapy in CKD
{{output}}
Background: CKD affects ∼15% of adults and remains a major cause of kidney failure and cardiovascular events. Several newer drug classes - sodium-glucose cotransporter-2 inhibitors, nonsteroidal mineralocorticoid receptor antago... ...
